Amicus Therapeutics, Inc. (FOLD)

NASDAQ: FOLD · Real-Time Price · USD

14.29

+0.02 (0.14%)

At close: Jan 30, 2026, 4:00 PM EST

14.24

-0.05 (-0.35%)

After-hours: Jan 30, 2026, 7:28 PM EST

Amicus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 30, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	4,420	2,815	4,161	3,430	3,218	6,017
Market Cap Growth	59.57%	-32.36%	21.31%	6.59%	-46.51%	142.44%
Enterprise Value	4,599	3,010	4,335	3,527	3,101	5,948
Last Close Price	14.29	9.42	14.19	12.21	11.55	23.09
Forward PE	56.64	87.63	-	-	-	-
PS Ratio	7.34	5.33	10.42	10.42	10.53	23.06
PB Ratio	19.13	14.51	25.98	27.88	10.47	21.01
P/TBV Ratio	247.15	-	-	-	29.37	67.93
EV/Sales Ratio	7.68	5.70	10.86	10.71	10.15	22.80
EV/EBITDA Ratio	109.19	70.63	-	-	-	-
EV/EBIT Ratio	133.24	88.35	-	-	-	-
Debt / Equity Ratio	1.92	2.29	2.78	3.67	1.43	1.54
Debt / EBITDA Ratio	9.04	8.61	-	-	-	-
Asset Turnover	0.72	0.68	0.53	0.40	0.34	0.30
Inventory Turnover	0.42	0.59	0.89	1.53	1.49	1.85
Quick Ratio	1.90	2.36	2.23	2.59	3.67	4.09
Current Ratio	2.99	3.39	2.88	3.05	4.09	4.47
Return on Equity (ROE)	-6.87%	-31.68%	-107.04%	-109.93%	-84.37%	-72.59%
Return on Assets (ROA)	2.61%	2.72%	-6.12%	-15.68%	-13.95%	-17.55%
Return on Capital Employed (ROCE)	5.20%	5.40%	-12.00%	-34.90%	-26.30%	-32.20%
Earnings Yield	-0.32%	-1.99%	-3.64%	-6.90%	-7.78%	-4.60%
FCF Yield	0.22%	-1.33%	-1.84%	-4.97%	-6.41%	-3.93%
Buyback Yield / Dilution	-1.52%	-3.12%	-2.11%	-6.50%	-4.85%	-7.67%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q